Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Interest Coverage Ratio of 36.46 for Q1 2026, down 562.21% on a YoY basis from 7.89 in Q1 2025, and down 200.27% sequentially from 12.14 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Interest Coverage Ratio data on file, last reported at 36.46 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 562.21% year-over-year to 36.46; the trailing twelve-month figure through Mar 2026 stood at 12.31 (down 172.73% YoY), and the FY2025 full-year result was 5.63, up 47.01% from the prior year.
- Interest Coverage Ratio declined to 36.46 in Q1 2026, from 12.14 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7.89 in Q1 2025 to a low of 39.09 in Q4 2023.
- A 5-year average of 6.62 and a median of 1.19 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 855.44% in 2022 and surged 1515.84% in 2025, its largest moves.
- Tracing CPIX's Interest Coverage Ratio over 5 years: stood at 12.69 in 2022, then tumbled by 207.99% to 39.09 in 2023, then surged by 78.89% to 8.25 in 2024, then plunged by 47.15% to 12.14 in 2025, then tumbled by 200.27% to 36.46 in 2026.
- Business Quant data shows CPIX's Interest Coverage Ratio at 36.46 in Q1 2026, 12.14 in Q4 2025, and 0.75 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -36.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.46 |
| Dec 31, 2025 | -12.14 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -1.01 |
| Mar 31, 2025 | 7.89 |
| Dec 31, 2024 | -8.25 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -39.09 |
| Sep 30, 2023 | -0.52 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | -2.52 |
| Dec 31, 2022 | -12.69 |
| Sep 30, 2022 | -1.19 |
| Jun 30, 2022 | -3.46 |
| Mar 31, 2022 | -1.57 |
| Dec 31, 2021 | 689.03 |
| Sep 30, 2021 | -1.11 |
| Jun 30, 2021 | -15.53 |